• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Tuesday, January 19, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

The NIH funds a $9.3 million Center for Precision Animal Modeling at UAB

Bioengineer by Bioengineer
October 9, 2020
in Biology
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Precision disease modeling involves creation of patient-specific disease models that mimic the molecular character of a condition present in a patient, enabling more precise diagnoses and treatments.

IMAGE

Credit: UAB

BIRMINGHAM, Ala. – A new Center for Precision Animal Modeling, or C-PAM, has been created at the University of Alabama at Birmingham, supported by a five-year, $9.3 million grant from the National Institutes of Health’s Office of Research Infrastructure Programs.

The UAB C-PAM is one of only three centers in the United States funded through a highly competitive NIH program to create national centers for “precision disease modeling.” UAB submitted a 15-member team proposal led by Brad Yoder, Ph.D., chair of the UAB Department of Cell, Developmental and Integrative Biology, and Matt Might, Ph.D., professor in the UAB Department of Medicine and director of the Hugh Kaul Precision Medicine Institute.

Yoder and Might say the new center is a recognition of UAB’s national reputation for leadership in both precision medicine and model organism research.

Precision disease modeling involves creation of patient-specific disease models — often using yeast, worms, fruit flies, zebrafish, frogs, mice or rats — that mimic the molecular character of a condition present in a patient. For example, if a patient has a disease caused by a sequence variant leading to the dysfunction of a gene, then C-PAM will create an animal model with this same variant. Studying the effect that the variant has in the model makes it possible to do science that is not possible in the human patient.

Computational capabilities at UAB — including advanced data science and artificial intelligence — will help predict possible treatments that can be tested in the models. Therapies that help treat the model would then become candidates for treatment of the patient.

Biology and medicine have used animal models to help understand disease for centuries, often by painstakingly breeding lines of animals that have, or are predisposed to have, a specific disease. By taking advantage of recent advances in genetic engineering at UAB and elsewhere, C-PAM’s transformative leap will make animal model research directly available to individual patients and their physicians. The use of such models can confirm tentative or novel diagnoses and aid the search for possible treatments, some of which could be unique to the patient.

Underlying the need for C-PAM is the recognition that every undiagnosed disease program at research universities, including UAB’s Undiagnosed Diseases Program, faces a huge problem. While they have identified significant numbers of genomic variants, they still lack sufficient functional evidence for clinical reporting and clinical treatment. The C-PAM approach can reveal whether a genomic variant in a patient is causal of the disease, determine its significance for gene function and disease pathophysiology, and identify and evaluate therapeutic targets.

A distinguishing feature of the UAB C-PAM is the establishment of direct interfaces and services for physicians and patients, in addition to services for other scientists. C-PAM will allow a treating physician to request the creation of a customized model for a patient, and the physician can work with C-PAM to further understand the disease and potential treatment.

Operationally, C-PAM will have five interconnected components to bring cutting-edge, precision disease modeling to patients. They are the:

  • Coordinating Component, led by Yoder and Might;

  • Pre/Co-Clinical Component, led by Bruce Korf, M.D., Ph.D., Might and Andy Crouse, Ph.D.;

  • Bioinformatics Component, led by Brittany Lasseigne, Ph.D., and Elizabeth Worthey, Ph.D.;

  • Disease Modeling Unit, led by Yoder, Robert Kesterson, Ph.D., and Craig Powell, M.D., Ph.D.; and

  • Resource and Services Component, led by Deeann Wallis, Ph.D.

The Disease Modeling Unit will host cores that have expertise in each model: 1) frogs, led by Chinbei Chang, Ph.D.; 2) nematode worms, led by Yoder and Courtney Haycraft, Ph.D.; 3) zebrafish, led by John Parant, Ph.D., and Matthew Alexander, Ph.D.; 4) mice, led by Kesterson; and 5) rats, led by Laura Lambert, Ph.D. Powell will oversee efforts in behavioral phenotyping, while Jeremy Foote, Ph.D., will oversee anatomical phenotyping.

C-PAM, Yoder and Might say, will leverage UAB’s existing expertise to create a national resource for efficient and cost-effective analysis of pathogenicity of gene variants identified in patients with rare disorders. Its informative models will help pursue disease mechanisms and targeted therapeutics.

###

Media Contact
Jeff Hansen
[email protected]

Original Source

https://www.uab.edu/news/research/item/11605-the-nih-funds-a-9-3-million-center-for-precision-animal-modeling-at-uab

Tags: Developmental/Reproductive BiologyGeneticsMedicine/HealthMetabolism/Metabolic Diseasesneurobiology
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

New approach emerges to better classify, treat brain tumors

January 19, 2021
IMAGE

New drug combination shows promise as powerful treatment for AML

January 19, 2021

New management approach can help avoid species vulnerability or extinction

January 18, 2021

Eliminating microplastics in wastewater directly at the source

January 18, 2021
Next Post
IMAGE

Spitzer space telescope legacy chronicled in Nature Astronomy

IMAGE

Hubble sees swirls of forming stars

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    The map of nuclear deformation takes the form of a mountain landscape

    53 shares
    Share 21 Tweet 13
  • Blood pressure drug may be key to increasing lifespan, new study shows

    44 shares
    Share 18 Tweet 11
  • New drug form may help treat osteoporosis, calcium-related disorders

    39 shares
    Share 16 Tweet 10
  • People living with HIV face premature heart disease and barriers to care

    59 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

MaterialsGeneticsBiologyClimate ChangeChemistry/Physics/Materials SciencesMedicine/HealthInfectious/Emerging DiseasesEcology/EnvironmentTechnology/Engineering/Computer SciencecancerPublic HealthCell Biology

Recent Posts

  • A clinical trial provides encouraging results on ivermectin for reducing mild COVID-19
  • New approach emerges to better classify, treat brain tumors
  • New drug combination shows promise as powerful treatment for AML
  • Green med diet cuts non-alcoholic fatty liver disease by half – Ben-Gurion U. study
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In